Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers; D008076:Cholesterol, HDL / Q000097:blood*; D000068800:Etanercept; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007074:Immunoglobulin G / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000150:complications* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000097:blood / Q000150:complications; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism*; D012720:Severity of Illness Index; D014280:Triglycerides / Q000097:blood*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D015854:Up-Regulation
D015415:Biomarkers; D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept